Protocols
1 protocol(s) meet the specified criteria
Drug: Pevonedistat
Protocol No.TitleStatus
PEVONEDISTAT-3001Pevonedistat-3001 A Phase 3, Randomized, Controlled, Open-label, Clinical Study of Pevonedistat Plus Azacitidine versus Single-Agent Azacitidine as First-Line Treatment for Patients With Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Low-Blast Acute Myelogenous LeukemiaOpen